Abstract
Abstract This article provides a discussion of the use of computed tomography (CT) and magnetic resonance (MR) imaging in the preoperative evaluation of intraabdominal metastatic disease from colorectal cancer. Many technologic advances, including the development of MR contrast agents, have significantly improved these modalities' ability to detect, characterize, and evaluate the extent of metastatic disease. State of the art helical CT and MR imaging with contrast agents have essentially replaced CT arterial portography in most practices. Continued advances in CT and MR along with use of positron emission tomography with 2–[ 18 F] fluoro–2–deoxy–D–glucose (FDG–PET) will continue to improve the accuracy of preoperative imaging for colorectal cancer patients. Copyright © 2002 by W.B. Saunders Company
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call